| Literature DB >> 22515314 |
Setareh Jahfari, Manoj Fonville, Paul Hengeveld, Chantal Reusken, Ernst-Jan Scholte, Willem Takken, Paul Heyman, Jolyon M Medlock, Dieter Heylen, Jenny Kleve, Hein Sprong.
Abstract
BACKGROUND: Neoehrlichia mikurensis s an emerging and vector-borne zoonosis: The first human disease cases were reported in 2010. Limited information is available about the prevalence and distribution of Neoehrlichia mikurensis in Europe, its natural life cycle and reservoir hosts. An Ehrlichia-like schotti variant has been described in questing Ixodes ricinus ticks, which could be identical to Neoehrlichia mikurensis.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22515314 PMCID: PMC3395572 DOI: 10.1186/1756-3305-5-74
Source DB: PubMed Journal: Parasit Vectors ISSN: 1756-3305 Impact factor: 3.876
Reported human cases ofinfection (until October 2011)
| Germany | Male, 69yr | Episodes of fever, nonproductive cough, left thoracic pain, vein thrombosis, hypochromic anemia, reduced numbers of leukocytes, decreased percentage of lymphocytes, increased proportion of monocytes and elevated levels of CRP, microbiological analysis were negative. | [ |
| Germany | Male, 57yr | Headaches, fever, intracerebral and subarachnoid hemorrhage, aneurysm, elevated CRP, pulmonary infiltration, microbiological analyses were negative, elevated infection parameters. Patient died from septic multi-organ failure. | [ |
| Sweden | Male, 77yr | Transitory ischemic attack, hemolytic anemia, fever, erysipelas-like rash, transitory weakness of the left side of face and arm, hemolytic anemia, thrombocytopenia, thrombosis, pulmonary infiltration, increased proportion of monocytes and elevated levels of CRP, blood and other cultures were negative | [ |
| Switzerland | Male, 61yr | Malaise, fever, moderate dyspnea, elevated leukocytes/neutrophils, elevated CRP, microbiological analysis were negative | [ |
| Czech Republic | Female 55 yr | Spiking fever, myalgias, arthralgias, erthema nodosum, elevated CRP, blood-, urine culture and pharyngeal swabs were negative. Antinuclear-, antinucleolar antigens and rheumatoid factor screens were negative. | [ |
| Czech Republic | Male, 58yr | Spiking fever, extreme fatigue, joint pain, skin erythema, painful and stiffened subcutaneous veins, mild leukocytosis and elevated CPR, blood and urine cultures and pharyngeal swab were negative. | [ |
Primers used for amplification and sequencing of gltA and GroEL genes of, and the amplification of the Msp2 gene of
| gltA | NMik fo-gltA | Primer (forward) | 5’-aagtgcatgctttgctacatt-‘3 | This study |
| gltA | NMik re-gltA | Primer (reverse) | 5’-tcatgatctgcatgtaaaataaat-‘3 | This study |
| GroEL | NMikGroEL-F2a | Primer (forward) | 5’-ccttgaaaatatagcaagatcaggtag-‘3 | This study |
| GroEL | NMikGroEL-R2b | Primer (reverse) | 5’-ccaccacgtaacttatttagtactaaag -‘3 | This study |
| GroEL | NMikGroEL-P2a | Probe (RED) | 5’-RED-cctctactaattattgctgaagatgtagaaggtgaagc-BHQ2-‘3 | This study |
| GroEL | NMik fo-groEL | Primer (forward) | 5’-gaagyatagtytagtatttttgtc-‘3 | [ |
| GroEL | NMik re-groEL | Primer (reverse) | 5’-ttaacttctacttcacttgaacc-‘3 | [ |
| GroEL | NMik seq1groEL | Primer (reverse) | 5’-acatcacgcttcatagaaag-‘3 | [ |
| GroEL | NMik seq2groEL | Primer (forward) | 5’-aaaggaattagtattagaatcttt-‘3 | [ |
| GroEL | NMik seq3groEL | Primer (forward) | 5’-aatatagcaagatcaggtagac-‘3 | [ |
| GroEL | NMik seq4groEL | Primer (reverse) | 5’-cttccattttaactgctaattc-‘3 | [ |
| Msp2 | ApMSP2F | Primer (forward) | 5’-atggaaggtagtgttggttatggtatt-‘3 | [ |
| Msp2 | ApMSP2R | Primer (reverse) | 5’-ttggtcttgaagcgctcgta-‘3 | [ |
| Msp2 | ApMSP2P | Probe (FAM) | 5’-FAM-tggtgccagggttgagcttgagattg-BHQ1-‘3 | [ |
Primers were either identical to or slightly modified from the primers described in the reference papers.
Members of thegroup are distinguished from other genera based on sequence analysis of 16S rDNA, citrate synthase (gltA) and heat shock protein GroEL genes
| Netherlands [ | 16S | AF104680 | 100% | ||
| Russia [ | 16S | AF104680 | 100% | ||
| Germany [ | 16S | AF104680 | 100% | ||
| Italy [ | 16S | AY098730 | 100% | ||
| Italy [ | 16S | AY098730 | 100% | ||
| China [ | 16S | AY135531 | 98.9% | ||
| Japan [ | 16S | AB084582 | 99.1% | ||
| USA [ | 16S | AY781777 | 99.8% | ||
| Japan [ | 16S | AB196304 | 99.5% | ||
| Russia [ | 16S | AF104680 | 100% | ||
| Italy [ | 16S | AB213021 | 99.6% | ||
| Russia [ | 16S | EF445398 | 100% | ||
| USA [ | 16S | EF633744, | 97.8% | ||
| Slovakia [ | 16S | AB196305 | 99.7% | ||
| Russia [ | 16S | FJ966364 | 99.6% | ||
| Germany [ | Human | 16S, | EU810404 | 99.9% | |
| Switzerland [ | Human | 16S | GQ501089 | 100% | |
| Germany [ | Dog | GroEL | EU432375 | 100% |
This strain has been reported in different parts of the world under diverse nominations. The similarity of these isolates with N. mikurensis isolates present in Dutch ticks isolates were calculated.
Figure 1Phylogenetic tree of the GroEL (top) and gltA (bottom) of different Anaplasma and Ehrlichia species and their relation withand related species.Ehrlichia schotti/N. mikurensis sequences from I. ricinus (n = 26) and rodents (n = 11), which were generated in this study are depicted in bold. Other GroEL and gltA sequences were taken from Genbank. Their accession numbers are shown between brackets. The evolutionary distance values were determined by the method of Kimura, and the tree was constructed according to the neighbour-joining method. Bootstrap values higher than 90%, are indicated at the nodes.
The prevalence and distribution ofin questingin the Netherlands and Belgium
| Boswachterij Hardenberg | 90 | 7 | 8% (3-15%) |
| Dintelse Gorzen | 122 | 9 | 7% (3-14%) |
| Drents-Friese Wold | 29 | 1 | 3% (0-18%) |
| Duin en Kruidberg (2009) | 320 | 52 | 16% (12-21%) |
| Duin en Kruidberg (2010) | 137 | 11 | 8% (4-14%) |
| Hoog Soeren | 217 | 3 | 1% (0-4%) |
| Kop van Schouwen | 238 | 23 | 10% (6-14%) |
| Denekamp | 104 | 4 | 4% (1-10%) |
| Pyramide van Austerlitz | 270 | 32 | 12% (8-16%) |
| Rijk van Nijmegen | 53 | 1 | 2% (0-10%) |
| Ulvenhoutse bos | 8 | 1 | 13% (0-53%) |
| Vijlenerbos | 328 | 10 | 3% (2-5%) |
| Vrouwenpolder | 86 | 6 | 7% (3-15%) |
| Brussel-area, (Sonian forest), (Belgium) | 153 | 0 | 0% (<2%) |
| Vlaanderen-area (Belgium) | 114 | 3 | 3% (1-8%) |
| Wallonië-area (Belgium) | 106 | 3 | 3% (1-8%) |
Confidence intervals (95%), which were calculated using Fisher's exact test, are between brackets. The average of all areas was calculated by average of all prevalence’s excluding Duin en Kruidberg 2009.
Prevalence ofin questing, divided by lifecycle stage
| Larvae | 55* | 0 | 0% (<1%) |
| Nymph | 2003 | 137 | 7% (6-8%) |
| Female | 92 | 10 | 11% (5-20%) |
| Male | 173 | 19 | 11% (7-17%) |
*Pools of 5 larvae. 95% Confidence intervals were calculated using Fisher's exact test and are between brackets.
andtested in the multiplex real-time PCR for the
| 79 | 0 | 0% (<5%) | |
| 169 | 0 | 0% (<2%) | |
| 177 | 0 | 0% (<2%) |
Confidence intervals (95%), which were calculated using Fisher's exact test.
Spleens of wild rodent and insectivore species were tested by PCR and sequencing usingspecific primers
| 2 | 0 | |
| 23 | 5 | |
| 5 | 0 | |
| 8 | 2 | |
| 35 | 4 | |
| 6 | 0 | |
adults feeding on animals living in nature reserve areas in the Netherlands were tested by multiplex real-time PCR for the presence of
| 409 | 26 | 6% (4-9%) | 17 | 10 | |
| 48 | 4 | 8% (2-20%) | 8 | 2 | |
| 264 | 33 | 13% (9-17%) | 24 | 13 | |
| 233 | 10 | 4% (2%-8%) | 18 | 4 |